French pharma major Sanofi (Euronext: SAN) has received a Complete Response Letter (CRL) from the US regulator for ...

Neok Biotech’s $75 million series A venture round, which took the California-based biotech out of stealth mode, was not the ...

Japanese pharma major Shionogi announced the conclusion of a joint research and development agreement and investment ...

German biosimilars specialist Formycon (FWB: FYB) has won US approval for Nufymco (ranibizumab), an interchangeable ...

Artificial intelligence remains the most impactful technology shaping the pharmaceutical industry, with companies ...

Japan’s Senju Pharmaceutical has announced that Avarept ophthalmic suspension 0.3% (motugivatrep), discovered and licensed by ...

French pharma major Sanofi today revealed it has agreed to acquire Dynavax Technologies, a US vaccines company with a ...

China’s rise as a biopharma innovator is reshaping global drug development, underpinned by regulatory reform and a rapidly ...

Once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) therapy has moved into a new phase with Food and Drug ...

US biotech Biogen said final Phase III data published in JAMA Neurology support earlier use of Qalsody (tofersen) in patients ...

British pharma AstraZeneca (LSE: AZN) said a Phase III study of ceralasertib combined with Imfinzi (durvalumab) failed to ...

Danish drugmaker Novo Nordisk (NOV: N) has secured US approval for an oral version of Wegovy (semaglutide), expanding access ...